Selective Targeting of mHTT Presents Novel Therapeutic Approach to Huntington’s Disease

Engineered zinc finger protein transcription factors show promise in Huntington’s disease research by selectively repressing mutant HTT, affirms an article published by PerkingElmer last Thursday October, 7,